Antibody-oligonucleotide Conjugates (AOCs) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 - QYResearch
The global market for Antibody-oligonucleotide Conjugates (AOCs) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ 525 million by 2031 with a CAGR of 147.2% during the forecast period 2025-2031.
AOCs (Antibody-Oligonucleotide Conjugates) consist of three main components: a carrier (antibody), a linker, and a small nucleic acid. They allow for targeted delivery, combining the antibody’s ability to bind to specific cells with the gene-silencing capability of small nucleic acids, addressing the delivery challenges faced by conventional small nucleic acid drugs.
https://www.qyresearch.com/reports/4518864/antibody-oligonucleotide-conjugates--aocs
